©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 14040-14050
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14040
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14040
Table 1 Characteristics of the included studies in the meta-analysis and quality assessment of studies of diagnostic accuracy scores
| Ref. | Country/region | Methylation of genes | n | CRC | Adenoma | Normal | Blind design | Detection method | QUADAS score | |||
| + | - | + | - | + | - | |||||||
| Ahlquist et al[10] 2012 | Ireland | Vimentin/NDRG4/BMP3/TFPI2 | 98 | 26 | 4 | 18 | 4 | 5 | 41 | Yes | QuARTS | 11 |
| Bosch et al[11] 2011 | The Netherlands | PHACTR3 | 185 | 40 | 25 | 6 | 13 | 4 | 97 | Unclear | qMSP | 10 |
| GATA4 | 160 | 29 | 11 | 3 | 16 | 6 | 95 | |||||
| OSMR | 185 | 25 | 40 | 4 | 15 | 7 | 94 | |||||
| Ahlquist et al[12] 2011 | Ireland | PHACTR3 | 639 | 214 | 38 | 51 | 43 | 29 | 264 | Yes | QuARTS | 11 |
| Azuara et al[13] 2010 | Spain | RARB2/P16/MGMT/APC | 98 | 25 | 13 | 20 | 20 | 0 | 20 | Yes | MS-MCA | 10 |
| RARB2 | 85 | 11 | 23 | 7 | 31 | 0 | 13 | |||||
| P16 | 77 | 9 | 21 | 6 | 28 | 0 | 13 | |||||
| MGMT | 80 | 9 | 19 | 3 | 34 | 0 | 15 | |||||
| APC | 77 | 9 | 19 | 9 | 25 | 0 | 15 | |||||
| Tang et al[14] 2011 | China | SFRP2 | 262 | 142 | 27 | 29 | 34 | 2 | 28 | Yes | MSP | 9 |
| Baek et al[15] 2009 | South Korea | Vimentin/MGMT/MLH1 | 149 | 45 | 15 | 31 | 21 | 5 | 32 | Yes | MSP | 9 |
| MLH1 | 149 | 18 | 42 | 6 | 46 | 0 | 37 | |||||
| Vimentin | 149 | 23 | 37 | 8 | 44 | 0 | 37 | |||||
| MGMT | 149 | 31 | 29 | 19 | 33 | 5 | 32 | |||||
| Li et al[16] 2009 | United States | Vimentin | 80 | 9 | 13 | 9 | 11 | 2 | 36 | Unclear | Methyl-BEAMing | 5 |
| Melotte et al[17] 2009 | The Netherlands | NDRG4 | 150 | 42 | 33 | NR | NR | 3 | 72 | Yes | qMSP | 11 |
| Ausch et al[18] 2009 | United States | IGTA4 | 37 | NR | NR | 7 | 2 | 6 | 22 | Unclear | qMSP | 4 |
| Hellebrekers et al[19] 2009 | The Netherlands | GATA4 | 150 | 44 | 31 | NR | NR | 9 | 66 | Yes | qMSP | 10 |
| Mayor et al[20] 2009 | Spain | EN1 | 60 | 8 | 22 | NR | NR | 1 | 29 | Unclear | MS-MCA | 7 |
| Kim et al[21] 2009 | United States | OSMR/SFRP1 | 42 | 12 | 8 | 6 | 11 | 0 | 5 | Yes | qMSP | 9 |
| OSMR | 201 | 35 | 54 | 2 | 14 | 4 | 92 | |||||
| SFRP1 | 52 | 11 | 9 | 5 | 12 | 0 | 15 | |||||
| Nagasaka et al[22] 2009 | Japan | SFRP2 | 253 | 53 | 31 | 18 | 38 | 9 | 104 | Unclear | COBRA | 10 |
| RASSF2 | 253 | 38 | 46 | 7 | 49 | 6 | 107 | |||||
| Glöckner et al[23] 2009 | United States | TFPI2 | 129 | 44 | 14 | 7 | 19 | 2 | 43 | Yes | qMSP | 12 |
| Wang et al[24] 2008 | China | SFRP2 | 133 | 60 | 9 | 21 | 13 | 2 | 28 | Yes | MethyLight | 8 |
| Oberwalder et al[25] 2008 | Australia | SFRP2 | 19 | NR | NR | 6 | 7 | 0 | 6 | Yes | MethyLight | 9 |
| Itzkowitz et al[26] 2008 | United States | Vimentin | 80 | 9 | 13 | 9 | 11 | 2 | 36 | Yes | MSP | 13 |
| Huang et al[27] 2007 | China | SFRP2/HPP1/MGMT | 97 | 50 | 2 | 15 | 6 | 1 | 23 | Yes | MSP | 8 |
| SFRP2 | 97 | 49 | 3 | 11 | 10 | 1 | 23 | |||||
| HPP1 | 97 | 37 | 15 | 12 | 9 | 0 | 24 | |||||
| MGMT | 97 | 25 | 27 | 6 | 15 | 0 | 24 | |||||
| Itzkowitz et al[28] 2007 | United States | Vimentin/HLTF | 162 | 31 | 9 | NR | NR | 19 | 103 | Yes | MSP | 13 |
| HLTF | 162 | 15 | 25 | NR | NR | 9 | 113 | |||||
| Vimentin | 162 | 29 | 11 | NR | NR | 16 | 106 | |||||
| Abbaszadegan et al[29] 2007 | Hong kong | p16 | 45 | 5 | 20 | NR | NR | 0 | 20 | Unclear | MSP | 8 |
| Zhang et al[30] 2007 | Germany | SFRP1 | 44 | 16 | 4 | 7 | 0 | 2 | 15 | Yes | MSP | 9 |
| Leung et al[31] 2007 | Hong kong | SFRP2/MGMT/MLH1/HLTF/ATM/APC | 75 | 16 | 4 | 18 | 7 | 3 | 27 | Yes | MSP | 13 |
| SFRP2 | 75 | 6 | 14 | 3 | 22 | 2 | 28 | |||||
| MGMT | 75 | 4 | 16 | 3 | 22 | 0 | 30 | |||||
| MLH1 | 75 | 4 | 16 | 3 | 22 | 0 | 30 | |||||
| HLTF | 75 | 5 | 15 | 5 | 20 | 1 | 29 | |||||
| ATM | 75 | 5 | 15 | 5 | 20 | 0 | 30 | |||||
| APC | 75 | 4 | 16 | 4 | 21 | 0 | 30 | |||||
| Petko et al[32] 2005 | United States | MGMT/CDKN2A/MLH1 | 48 | NR | NR | 16 | 13 | 7 | 12 | Yes | MSP | 9 |
| CDKN2A | 48 | NR | NR | 9 | 20 | 3 | 16 | |||||
| MGMT | 48 | NR | NR | 14 | 15 | 5 | 14 | |||||
| MLH1 | 48 | NR | NR | 0 | 29 | 2 | 17 | |||||
| Lenhard et al[33] 2005 | Germany | HIC1 | 71 | 11 | 15 | 4 | 9 | 0 | 32 | Yes | MSP | 11 |
| Chen et al[34] 2005 | United States | Vimentin | 263 | 43 | 51 | 6 | 44 | 8 | 111 | Yes | MSP | 11 |
| Müller et al[35] 2004 | Australia | SFRP2/SFRP5 | 39 | 20 | 3 | NR | NR | 8 | 8 | Unclear | MethyLight | 5 |
| SFRP2 | 39 | 19 | 4 | NR | NR | 4 | 12 | |||||
| SFRP5 | 39 | 18 | 5 | NR | NR | 5 | 11 | |||||
| Xu et al[36] 2012 | China | SFRP2 | 90 | 20 | 10 | 15 | 15 | 1 | 29 | Unclear | MSP | 5 |
| Kang et al[37] 2011 | China | MGMT/MAL/CDKN2A | 119 | 64 | 5 | 17 | 7 | 2 | 24 | Unclear | MSP | 7 |
| MAL | 119 | 54 | 15 | 14 | 10 | 1 | 25 | |||||
| CDKN2A | 119 | 36 | 33 | 10 | 14 | 0 | 26 | |||||
| MGMT | 119 | 38 | 31 | 9 | 15 | 1 | 25 | |||||
| Zhang et al[38] 2011 | China | Vimentin/OSMR/TFPI2 | 107 | 52 | 8 | 13 | 4 | 4 | 26 | Unclear | MSP | 9 |
| Vimentin | 107 | 32 | 28 | 5 | 12 | 0 | 30 | |||||
| OSMR | 107 | 41 | 19 | 7 | 10 | 0 | 30 | |||||
| TFPI2 | 107 | 45 | 15 | 11 | 6 | 4 | 26 | |||||
| Fu et al[39] 2010 | China | Vimentin | 22 | 5 | 9 | NR | NR | 0 | 8 | Unclear | MSP | 5 |
| Ling et al[40] 2009 | China | P16 | 108 | 47 | 14 | 16 | 11 | 1 | 19 | Unclear | MSP | 7 |
| Cheng et al[41] 2007 | China | SFRP2 | 97 | 49 | 3 | 11 | 10 | 1 | 23 | Unclear | MSP | 5 |
| Zhao et al[42] | China | NDRG4 | 114 | 64 | 20 | NR | NR | 3 | 27 | Unclear | MSP | 6 |
| 2009 | ||||||||||||
| Chang et al[43] 2010 | South Korea | IGTA4/SFRP2/P16 | 86 | 21 | 9 | 18 | 7 | 1 | 30 | Yes | MSP | 8 |
| IGTA4 | 86 | 11 | 19 | 4 | 21 | 0 | 31 | |||||
| SFRP2 | 86 | 18 | 12 | 11 | 14 | 0 | 31 | |||||
| P16 | 86 | 12 | 18 | 6 | 19 | 1 | 30 | |||||
| Zhang et al[44] 2013 | China | SPG20 | 126 | 77 | 19 | NR | NR | 0 | 30 | Unclear | MSP | 7 |
| Carmona et al[45] 2013 | Spain | AGTR1/WNT2/SLIT2 | 102 | 50 | 14 | NR | NR | 4 | 34 | Unclear | Pyrosequencing | 10 |
| AGTR1 | 107 | 14 | 54 | NR | NR | 2 | 37 | |||||
| WNT2 | 91 | 21 | 31 | NR | NR | 1 | 38 | |||||
| SLIT2 | 108 | 37 | 34 | NR | NR | 2 | 35 | |||||
| 9-Sep | 61 | 7 | 28 | NR | NR | 0 | 26 | |||||
| Vimentin | 55 | 18 | 15 | NR | NR | 3 | 19 | |||||
| Guo et al[46] 2013 | China | FBN1 | 105 | 54 | 21 | NR | NR | 2 | 28 | MSP | 6 | |
- Citation: Zhang H, Qi J, Wu YQ, Zhang P, Jiang J, Wang QX, Zhu YQ. Accuracy of early detection of colorectal tumours by stool methylation markers: A meta-analysis. World J Gastroenterol 2014; 20(38): 14040-14050
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/14040.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.14040